Senti Biosciences, based in South San Francisco, has completed a $53 million Series A financing. Source: BioSpace

Eli Lilly snagged regulatory approval for expanded use of cancer treatment Verzenio. Source: BioSpace

Pfizer is fighting to preserve Lyrica’s use as the preferred physician’s treatment for nerve pain in the U.K. Source: BioSpace

Beijing-based Yisheng Biopharma Co. is celebrating this morning after its lead immunology treatment snagged a second Orphan Drug Designation from the U.S. Food and Drug Administration. Source: BioSpace

ObsEva Sa highlighted a data point from a late-stage trial that showed its fertility treatment nolasiban was successful in improving the pregnancy rate of some women following in vitro fertilization.…

Eli Lilly and Company published results from a new Phase IIIb clinical trial of Trulicity (dulaglutide) in combination with a sodium-glucose co-transporter-2 (SGLT-2) inhibitor, which has shown improved blood sugar…

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) announced a string of approvals, as well as a couple rejections. Source: BioSpace

Vertex Pharmaceuticals announced that Reshma Kewalramani will be the new chief medical officer and executive vice president, Global Medicines Development and Medical Affairs Source: BioSpace

Patients are discovering that Teva’s generic isn’t really that much cheaper than Valeant Pharmaceutical’s branded drug to treat Wilson's Disease. Source: BioSpace

U.S. Patent Trial and Appeal Board denies St. Regis Mohawk Tribe's motion to terminate Restasis patent challenge. Source: BioSpace